Thought Leadership
32 GenAI in healthcare: why privacy and literacy matter more than the tech
26 January 2026Thought Leadership
31 Pandemic readiness is now a financial risk test – and the UK must treat it that way
26 January 2026Thought Leadership
28-30 The race to explore and harness GenAI in healthcare
26 January 2026Thought Leadership
27 AI-enabled, human-interpreted: the future of pharma marketing insights is precision intelligence
26 January 2026Thought Leadership
34-35 Communication breakdown
26 January 2026Thought Leadership
32 - 33 Pandemic readiness is now a financial risk test – and the UK must treat it that way
26 January 2026Thought Leadership
30-31 TL SYNEOS HEALTH - Scaling AI in healthcare communications: from pilots to living systems
26 January 2026Thought Leadership
28-29 Designing healthcare AI that works for every patient
26 January 2026Thought Leadership
18-19 GLOBAL BREAST CANCER REPORT - OAdvanced Breast Cancer – a landmark Global Decade Report
CAR-Ts pose a unique challenge for healthcare systems, exacerbated by uncertainty around their long-term, real-world value
18 December 2025Thought Leadership
24 TL SYNEOS HEALTH - Predicting the future of health equity in the pharmaceutical industry
27 November 2025Thought Leadership
26 TL ASPIRE - The building of Aspire Pharma and values
27 November 2025Thought Leadership
20-22 CLINICAL PATHWAYS - Optimised therapy to improve outcomes for heart attack and stroke patients
CAR-Ts pose a unique challenge for healthcare systems, exacerbated by uncertainty around their long-term, real-world value
27 November 2025Thought Leadership
Pharmaceutical Market Europe (PME)
Pharmaceutical industry news, articles, jobs, reports, advice and services